Stay updated on Budesonide in Eosinophilic Esophagitis Maintenance Trial
Sign up to get notified when there's something new on the Budesonide in Eosinophilic Esophagitis Maintenance Trial page.

Latest updates to the Budesonide in Eosinophilic Esophagitis Maintenance Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page now shows the ClinicalTrials.gov record for EOS-2, a completed Phase 3 study comparing two budesonide doses with placebo for maintaining remission in adults with eosinophilic esophagitis. It includes the study design, participant criteria, outcomes, and study dates.SummaryDifference44%

- Check18 days agoChange DetectedThe site footer now displays revision v3.8.0 instead of v3.7.2, while the study record area continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check25 days agoChange DetectedA banner announces NIH website-transition updates, including a change in terminology from “Artificial Intelligence” to “Super Intelligence” in some NIH content.SummaryDifference1%

- Check32 days agoChange DetectedThe footer revision identifier changed from v3.7.1 to v3.7.2 on the 403 error page, while the study record remains unavailable.SummaryDifference0.2%

- Check39 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check60 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the expected study content with an access-denied message. This indicates the study record is unavailable to view at the moment.SummaryDifference17%

Stay in the know with updates to Budesonide in Eosinophilic Esophagitis Maintenance Trial
Enter your email address, and we'll notify you when there's something new on the Budesonide in Eosinophilic Esophagitis Maintenance Trial page.